Article Text

Download PDFPDF

A survey of early health effects of the Eyjafjallajökull 2010 eruption in Iceland: a population-based study
  1. Hanne Krage Carlsen1,
  2. Thorarinn Gislason2,3,
  3. Bryndis Benediktsdottir2,3,
  4. Thorir Bjorn Kolbeinsson4,
  5. Arna Hauksdottir1,
  6. Throstur Thorsteinsson5,
  7. Haraldur Briem6
  1. 1Centre of Public Health Sciences, University of Iceland, Reykjavik, Iceland
  2. 2Faculty of Medicine, University of Iceland, Reykjavik, Iceland
  3. 3Department of Respiratory Medicine and Sleep, Landspitali University Hospital, Reykjavik, Iceland
  4. 4Primary Health Care Centre of South Iceland, Hella, Iceland
  5. 5Environment and Natural Resources and Institute of Earth Sciences, University of Iceland, Reykjavik, Iceland
  6. 6Centre for Health Security and Communicable Disease Control, Directorate of Health, Reykjavik, Iceland
  1. Correspondence to Dr Haraldur Briem; hbriem{at}landlaeknir.is

Abstract

Objective To estimate physical and mental health effects of the Eyjafjallajökull volcanic eruption on nearby residents.

Design Cross-sectional study.

Setting The Icelandic volcano Eyjafjallajökull erupted on 14 April 2010. The eruption lasted for about 6 weeks and was explosive, ejecting some 8 million tons of fine particles into the atmosphere. Due to prevailing winds, the ash spread mostly to the south and south-east, first over the rural region to the south, later over the Atlantic Ocean and Europe, closing European air space for several days.

Participants Residents (n=207) of the most ash-exposed rural area south and east of the volcano.

Methods The study period was from 31 May to 11 June 2010. Participants were examined by a physician. To ascertain respiratory health, standardised spirometry was performed before and after the use of a bronchodilator. All adult participants answered questionnaires about mental and physical health, their children's health and the use of protective equipment.

Results Every other adult participant reported irritation in eyes and upper airway when exposed to volcanic ash. Adults (n=26) and children (n=5) with pre-existing asthma frequently reported worsening of their symptoms. No serious health problems requiring hospitalisation could be attributed to the eruption. The majority of the participants reported no abnormal physical or mental symptoms to the examining physician. Compared to an age- and gender-matched reference group, the ash-exposed participants reported lower smoking rates and were less likely to have ventilation impairment. Less than 10% of the participants reported symptoms of stress, anxiety or depression.

Conclusions Short-term ash exposure was associated with upper airway irritation symptoms and exacerbation of pre-existing asthma but did not contribute to serious health problems. The exposure did not impair respiratory function compared to controls. Outdoor use of protective glasses and face masks was considered protective against irritation in eyes and upper airway.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.

View Full Text

Statistics from Altmetric.com

Footnotes

  • To cite: Carlsen HK, Gislason T, Benediktsdottir B, et al. A survey of early health effects of the Eyjafjallajökull 2010 eruption in Iceland: a population-based study. BMJ Open 2012;2:e000343. doi:10.1136/bmjopen-2011-000343

  • Contributors All authors were involved in designing the study, interpreting the results and drafting the article. TG and BB conducted the medical examinations, HKC and AH implemented the questionnaires, TBK recruited the participants, TT analysed the data on the ash and ash fall and HB initiated this study and collected all data.

  • Funding Funded by the Ministry of Welfare. The Health Authorities.

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval Icelandic Health Authorities. According to Icelandic legislation (Act no. 19/1997 on Health Security and Communicable Diseases), incidents concerning public health threats are to be investigated without delay such as urgent outbreak investigations. Ethics approval may take some time and could not possibly be obtained before this investigation started.

  • Provenance and peer review Commissioned according to the Act on Health Security and Communicable Disease Control No. 19/1997. Externally peer reviewed.

  • Data sharing statement The authors are willing to share all available data. There are additional unpublished data on spirometric measurements available if requested.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.